Loading…
bwge2017 has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Type: BGDO [clear filter]
Friday, February 10
 

14:00 CET

Primary tumor sidedness has an impact on prognosis and treatment outcome: results from three randomized studies of panitumumab plus chemotherapy versus chemotherapy (plus bevacizumab) in 1st and 2nd line RAS/BRAF... Room LIJN 3rd floorNele Boeckx

14:13 CET

Interleukin 15-stimulated natural killer cells can kill both pancreatic cancer and stellate cells Room LIJN 3rd floorEvelien Smits

14:26 CET

Characterization of the immune microenvironment and relation to preoperative treatment of synchronous resection of primary tumor and liver colorectal cancer metastases. Room LIJN 3rd floorMarc VANDENEYNDE

14:39 CET

Prognostic relevance of pancreatic neuroendocrine tumors grading on EUS-FNA Room LIJN 3rd floorIvan BORBATH

14:52 CET

Retrospective study on the incidence of chemotherapy side effects and evaluation of the Hurria score and G8 CGA as predictive tools for toxicity in older patients with gastrointestinal cancer. Room LIJN 3rd floorMarc De Man

15:05 CET

Pressurized intraperitoneal aerosol chemotherapy (PIPAC), a new surgical technique for the treatment of unresectable peritoneal carcinomatosis Room LIJN 3rd floorWouter Willaert

15:20 CET

Coffee break Exhibition Area Room Belle

15:45 CET

State-of-the-art lecture: Treatment of borderline resectable pancreatic Cancer: what is the optimal induction treatment? Room LIJN 3rd floorThierry Conroy (Institut de Cancérologie Lorraine Nancy France)

16:15 CET

Upper GI cancers Room LIJN 3rd floorKaren Geboes (UZ Gent)

16:40 CET

Hepato-Bilio-Pancreatic cancers Room LIJN 3rd floorFrancesco Puleo (ULB Erasme)

17:05 CET

Colo-Rectal cancers Room LIJN 3rd floorMarc Peeters (UZ Antwerpen)